About the Journal

The journal of InnovoMedica (INNMED) (ISSN:2959-0280) is a leading journal that keens to publish latest findings on clinical research and medical sciences. The journal is under the auspice of  Knowledge University, a leading private university that provides high quality education and emphasize research and innovation. INNMED is to be a defined and refined source for researchers addressing the latest discoveries in the medical fields and clinical findings. Physicians, nurses, pharmacists, dentists, and other medical practitioners are the beneficiaries. The journal encourages authors to share their research findings and to engage in cross-disciplinary collaboration. INNMED is keen to publish novel investigations, new findings, and up-to-date approaches in all fields of medical sciences, biomedical research, molecular medicine, clinical findings and cases. The journal mission is to be a reliable source of advanced knowledge and innovative findings in medical fields.

Readership and scope are broad.

INNOVOMEDICA presents latest findings in the medical sciences and clinical reserch to a wide variety of audiences. This include publications in basic and translational medicine, clinical findings, biomedical approaches. Such a network of medical disciplines can create an exceptional source and reference for those who are interestes in the latest findings in this vital sector of life and wellbeing. 

Open Access.

In InnovoMedica, all research and publication materials are freely available to the public. The journal ensures the reach of its publications to the widest audience coverage through presenting the articles in well-known databases.

Editorial Board. Renowned international experts on the Journal's Editorial Board and external peer reviewers select the best submissions for publication.

 

PEER REVIEW PROCESS
All published articles in InnoveMedica journal undergo a rigorous peer review process based on an initial screening from the editors and two blind peer reviews.

  • The journal peer review process is a "double blind peer review".
  • Simultaneous submissions of the same manuscript to different journals will not be tolerated.
  • Manuscripts with contents outside the scope will not be considered for review.
  • All submitted manuscripts are treated as confidential documents. We expect our Board of Reviewing Editors, Section Editors and reviewers to treat manuscripts as confidential material as well.
  • Editors, Associate Editors and reviewers involved in the review process should disclose conflicts of interest resulting from direct competitive, collaborative, or other relationships with any of the authors, and remove oneself from cases in which such conflicts preclude an objective evaluation. Privileged information or ideas that are obtained through peer review must not be used for competitive gain.

The blind peer review/publication process includes:

  • The Author writes a research manuscript and submits it online through the Open Journal Systems.
  • The Editors do the initial screening and assign scholars in their area of expertise for blind reviews
  • The Reviewers review the manuscript according to the guidelines provided and verify the quality of research
  • The Reviewers return the manuscript to the Editors with a recommendation to reject, revise or accept it
  • The Editors draft a decision and send it to the Author with the Reviewers' feedback
  • The Author implements the recommended changes and sends it back to the Editors
  • The Editors make a final decision to either reject it or send it to publication

PUBLICATION ETHICS POLICY

Important tips of Publishing Ethics in InnovoMedica journal.

  1. Declare to your chosen journal that your manuscript is not published elsewhere;
  2. Declare any conflicts of interest;
  3. Check all co-authors meet criteria for authorship and ensure appropriate; acknowledgements made in the manuscript;
  4. Include appropriate funding statements in the manuscript;
  5. Show informed consent and provide assurances that participants’ rights are protected;
  6. Register clinical trials;
  7. Explain how research using animals is conducted responsibly;
  8. Be alert to bias and follow guidelines for accurate and complete reporting of research;
  9. Inform the journal if you subsequently find errors in your research
  10. Sign the online copyright agreement;

According to InnovoMedica guidelines any manuscripts received for review must be treated as confidential documents. Since peer review is a blin-peer-review, reviewers must not share the review or information about the review with anyone without the agreement of the editors and authors involved. This applies both during and after the publication process. We encourage all our reviewers to follow the journal guidelines.

Basic Principles
Authors submitting works to InnovoMedica journal warrant the following:

  1. Their article/chapter is original and free of copyrights;
  2. The work has not been submitted elsewhere, and is not under consideration with any other journal or publication;
  3. The work does not include libellous, defamatory or unlawful statements;
  4. Proof of consent has been obtained for any named individuals or organizations;
  5. Authorship has been agreed prior to submission and that no one has been ‘gifted’ authorship or denied credit as an author (“ghost authorship”).

Plagiarism
InnovoMedica journal uses plagiarism detection software. InnovoMedica requires that all research submitted to the journals or books is original and the author agrees to these terms upon assignment and acceptance.

Dual Submission/Publications
Authors are expected to submit original, previously unpublished content to us. It is unacceptable academic practice to submit to more than one journal at the same time – authors are expected to wait until receiving a decision from one journal before submitting to the next.

Conflict of interest
All conflicts of interest should be declared by the author, editor or reviewer. Examples include:
      1. A financial or personal interest in the outcomes of the research;
      2. Undisclosed financial support for the research by an interested third party;
      3. A financial or personal interest in the suppression of the research;

Text Recycling
Authors are expected to submit original content to us. It is only acceptable for research to be repeated if it leads to different or new conclusions or for comparisons with new data. In all cases, it is important to reference the previously published work. If any element of the work has been published previously, you must ensure that this work is fully referenced and state it at the point of submission so that the Editor may make a fully-informed decision.

Authorship issues
In multi-authored papers, it is important that all authors that have made a significant contribution to the paper are listed. Those who have provided support but have not contributed to the research should be acknowledged in an Acknowledgements section. Authorship issues fall into three main types:

Defamation/Lible
We require that authors obtain written “proof of consent” for studies about named organizations or people.

Ethical Committments
An author must follow appropriate international and national procedures with respect to data protection, rights to privacy, child protection and medical testing on humans and animals. Authors must make available all consent forms and requisite forms from the appropriate regulatory bodies to the Editor. If research is found to contravene international or national procedures, we will publish a retraction notice.

PUBLICATION FREQUENCY
InnovoMedica journal is published 2 times per year. Accepted papers are published online ahead of print. INNMED is published online when the process of peer-reviewing isfinalized. INNOVEMEDICA's hard-copy published  bianually with the first issue publishes the accepted papers during (January - June) and the second issue publishes the accepted papers during (July- December). The hard-copy of INNOVOMEDICA issues are published with all accepted online paper within each publication period.


ARTICLES PROCESSING/SUBMISSION CHARGES
InnovoMedica is an Open Access Journal (OAJ) and has neither article processing charge nor artcile submission charges (ASCs).